Albion Financial Group Astrazeneca PLC Transaction History
Albion Financial Group
- $1.29 Billion
- Q1 2024
A detailed history of Albion Financial Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Albion Financial Group holds 360 shares of AZN stock, worth $27,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360
Previous 360
-0.0%
Holding current value
$27,601
Previous $24,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,250Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.7 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.29 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.32 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...